ARID1A antibody | knockout validation | Abcam ab182560

This is a knockout-validated antibody summary, based on the publication "ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

ARID1A antibody | knockout validation | Abcam ab182560 figure 1
Figure 1. Western blot demonstrating effective inactivation of Apc and/or Arid1a in vivo. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: ARID1A

Catalog number: ab182560

Summary: Rabbit monoclonal antibody against a recombinant fragment of human ARID1A . Reacts with human. It is predicted to work with mouse and rat. Suitable for western blot, immunocytochemistry/immunofluorescence, immunohistochemistry (paraffin), and flow cytometry (intra).

Validation Method

Western blot | Immunohistochemistry

Sample

WT and Arid1a KO mouse livers.

Blocking agent

WB: 5% blocking reagent (Biorad 170–6404) in TBS/Tween 0.1% for 1 hr at RT.

Primary incubation

WB 1:2,000 dilution overnight.

IHC: 1:1,000 dilution.

Secondary incubation

WB: 1:2,000 dilution HRP-conjugated secondary antibody (Cell Signaling, 7074).

IHC: 1:200 dilution biotinylated goat anti-rabbit (Vector lab, BA-1000).

Detection

WB: Clarity ECL substrate (Biorad 70–5061).

References
  1. Riou R, Ladli M, Gerbal Chaloin S, Bossard P, Gougelet A, Godard C, et al. ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription. elife. 2020;9: pubmed publisher
  2. 1.
  3. Apc-Arid1a.